Physician profile
Fernando E Correa
NPI 1790765766
$3,303.54
in general payments reported to CMS, 2019-2025
16 companies · $435 in 2025
The $435 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42.03 · 2020: $82.03 · 2021: $520 · 2022: $944 · 2023: $679 · 2024: $603 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,716.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $1,654.44 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $424.17 | 2022-2024 | Qulipta, Ubrelvy |
| Novo Nordisk INC | $291.95 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Janssen Pharmaceuticals, INC | $267.98 | 2022-2023 | Spravato |
| Lilly USA, LLC | $185.67 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $96.36 | 2023-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.98 | 2022-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.86 | 2019-2022 | |
| Philips North America LLC | $55.19 | 2024 | (Ck4) Mcot |
| Sanofi-Aventis U.S. LLC | $48.05 | 2019-2020 | |
| Horizon Therapeutics Plc | $39.48 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $34.15 | 2020-2021 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $19.78 | 2022 | |
| Exact Sciences Corporation | $15.96 | 2025 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $15.04 | 2024 | Auvelity |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainsway USA INC | $14.48 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fernando Correa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.